Engystol ampoules 1.1 ml. №5

Description

Engystol ampoules Composition
active ingredients:

1.1 ml of solution contains: Sulfur D4 – 3.3 μl, Sulfur D10 – 3.3 μl, Vincetoxicum hirundinaria D6 – 6.6 μl, Vincetoxicum hirundinaria D10 – 6.6 μl;

Engystol ampoules excipients: sodium chloride, water for injection.

Engystol ampoules Dosage form
Injection.

Basic physical and chemical properties: colorless, transparent, odorless solution.

Pharmacological group
Complex homeopathic preparation.

Pharmacological properties

Pharmacodynamics.

The drug has an immunocorrective (indirect antiviral), anti-inflammatory, detoxification effect, regenerates the SH-groups of enzymes in case of intoxication, by activating the body’s defenses and normalizing its functions.

Pharmacokinetics.

Not defined for homeopathic remedies.

Indications
Acute and chronic infectious diseases of viral origin (hepatitis, cytomegalovirus infection, herpes, bronchitis, pneumonia, whooping cough, influenza, ARVI).

Contraindications
Hypersensitivity to the components of the drug.

Interaction with other medicinal products and other forms of interaction
Unknown.

Application features
If symptoms persist or if the condition worsens, you should consult your doctor.

At the beginning of treatment with the drug, a short-term exacerbation of the existing symptoms of the disease is possible (primary reaction). This reaction is usually temporary. If symptoms persist, the drug should be discontinued and a doctor should be consulted.

This medicinal product contains less than 1 mmol (23 mg) / dose of sodium, that is, it is practically free of sodium.

Application during pregnancy or lactation.

No adverse effects are known. The possibility of use is determined by the doctor if the benefit from the use of the drug outweighs the potential risk to the fetus / child.

The ability to influence the reaction rate when driving vehicles or other mechanisms. Unknown.

Method of administration and dosage
Single dose: adults and children from 6 years old – 1 ampoule of 1.1 ml. Apply 1-3 times a week in the form of intramuscular, subcutaneous, intravenous (jet) injections.

In acute cases – 1 ampoule daily for 3-5 days.

Treatment course: 2-5 weeks.

The duration of treatment depends on the severity and course of the disease and is determined individually.